Diabetic retinopathy-recommendations for screening and treatment

Area of Science:

• Ophthalmology
• Endocrinology
• Vascular Biology

Background:

• Diabetic retinopathy (DR) is a significant cause of global vision impairment, with increasing prevalence.
• DR pathogenesis involves complex interactions leading to retinal vascular abnormalities, ischemia, and neovascularization.
• Diabetic macular edema (DME) can occur at any stage of DR, from nonproliferative to proliferative forms.

Purpose of the Study:

• To summarize the current understanding of diabetic retinopathy pathogenesis.
• To highlight the importance of screening for early detection of diabetic eye disease.
• To review available treatment options for ocular diabetic complications.

Main Methods:

• Review of experimental and clinical research on DR pathogenesis.
• Classification of DR based on neovascularization presence.
• Overview of current therapeutic strategies for diabetic eye complications.

Main Results:

• DR involves abnormal retinal vasculature, ischemia, and neovascularization.
• DR is categorized into nonproliferative and proliferative forms.
• Effective treatments include anti-VEGF agents, corticosteroids, laser photocoagulation, and surgery.

Conclusions:

• Understanding DR pathogenesis is advancing.
• Screening is vital for preventing vision loss in diabetic patients.
• Multiple treatment options exist for managing diabetic retinopathy and its complications.